Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 1c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
• BofA lists top 5 themes driving next $1tn in incremental semi sales